A challenging case of tuberculosis-associated uveitis after corticosteroid treatment for Vogt-Koyanagi-Harada disease.
作者信息
Qian Tian-Wei, Yu Su-Qin, Xu Xun
机构信息
Department of Ophthalmology, Shanghai General Hospital, Shanghai 200080, China.
Shanghai Key Laboratory of Ocular Fundus Diseases, Shanghai 200080, China.
出版信息
Int J Ophthalmol. 2018 Aug 18;11(8):1430-1432. doi: 10.18240/ijo.2018.08.29. eCollection 2018.
Abstract
摘要
相似文献
1
A challenging case of tuberculosis-associated uveitis after corticosteroid treatment for Vogt-Koyanagi-Harada disease.一例在接受糖皮质激素治疗伏格特-小柳-原田病后发生结核相关性葡萄膜炎的疑难病例。
Int J Ophthalmol. 2018 Aug 18;11(8):1430-1432. doi: 10.18240/ijo.2018.08.29. eCollection 2018.
2
Applicability of the 2001 revised diagnostic criteria in Brazilian Vogt-Koyanagi-Harada disease patients.2001年修订的诊断标准在巴西Vogt-小柳-原田病患者中的适用性。
Arq Bras Oftalmol. 2008 Jan-Feb;71(1):67-70. doi: 10.1590/s0004-27492008000100014.
3
Vogt-koyanagi-harada syndrome.伏格特-小柳-原田综合征
Curr Eye Res. 2008 Jul;33(7):517-23. doi: 10.1080/02713680802233968.
4
[Vogt-Koyanagi-Harada syndrome in children].[儿童Vogt-小柳-原田综合征]
J Fr Ophtalmol. 2002 Jun;25(6):636-40.
5
Tuberculous Posterior Sclero-Uveitis with Features of Vogt-Koyanagi-Harada Uveitis: An Unusual Case.
Am J Case Rep. 2017 Apr 8;18:367-374. doi: 10.12659/ajcr.903304.
6
Vogt-Koyanagi-Harada disease-like posterior uveitis in the course of nivolumab (anti-PD-1 antibody), interposed by vemurafenib (BRAF inhibitor), for metastatic cutaneous malignant melanoma.在使用纳武单抗（抗PD-1抗体）治疗转移性皮肤恶性黑色素瘤过程中出现类似伏格特-小柳-原田病的后葡萄膜炎，期间使用了维莫非尼（BRAF抑制剂）。
Clin Case Rep. 2017 Mar 31;5(5):694-700. doi: 10.1002/ccr3.911. eCollection 2017 May.
7
Prevalence, clinical characteristics, and causes of vision loss in children with Vogt-Koyanagi-Harada disease in South India.印度南部 Vogt-Koyanagi-Harada 病患儿的患病率、临床特征和致盲原因。
Retina. 2010 Jul-Aug;30(7):1113-21. doi: 10.1097/IAE.0b013e3181c96a87.
8
Vogt-Koyanagi-Harada syndrome with focal neurologic signs.伴有局灶性神经体征的伏格特-小柳-原田综合征
Am J Ophthalmol. 1981 Mar;91(3):332-41. doi: 10.1016/0002-9394(81)90286-5.
9
Systemic corticosteroid treatment in Vogt-Koyanagi-Harada disease.Vogt-小柳-原田病的全身糖皮质激素治疗
Graefes Arch Clin Exp Ophthalmol. 1982;218(1):9-13. doi: 10.1007/BF02134092.
10
Association of HLA antigens with Vogt-Koyanagi-Harada syndrome in a Han Chinese population.汉族人群中 HLA 抗原与葡萄膜炎-小柳原田综合征的关联。
Arch Ophthalmol. 1991 Mar;109(3):368-70. doi: 10.1001/archopht.1991.01080030070041.
引用本文的文献
1
A Case of Vogt-Koyanagi-Harada Disease and Retinal Peri-Phlebitis in a Patient With Presumed Ocular Tuberculosis.一例疑似眼结核患者的Vogt-小柳-原田病合并视网膜静脉周围炎
Cureus. 2024 Jul 9;16(7):e64200. doi: 10.7759/cureus.64200. eCollection 2024 Jul.
2
Tubercular Harada disease - An unreported uveitic entity.结核性原田病——一种未被报道的葡萄膜炎类型。
Ann Med Surg (Lond). 2022 Jul 31;80:104294. doi: 10.1016/j.amsu.2022.104294. eCollection 2022 Aug.
本文引用的文献
1
Tuberculous Posterior Sclero-Uveitis with Features of Vogt-Koyanagi-Harada Uveitis: An Unusual Case.
Am J Case Rep. 2017 Apr 8;18:367-374. doi: 10.12659/ajcr.903304.
2
Prevention and management of glucocorticoid-induced side effects: A comprehensive review: Infectious complications and vaccination recommendations.预防和管理糖皮质激素诱导的副作用：全面综述：感染性并发症和疫苗接种建议。
J Am Acad Dermatol. 2017 Feb;76(2):191-198. doi: 10.1016/j.jaad.2016.02.1240.
3
Vogt-Koyanagi-Harada disease: Novel insights into pathophysiology, diagnosis and treatment.Vogt-Koyanagi-Harada 病：发病机制、诊断和治疗的新见解。
Prog Retin Eye Res. 2016 May;52:84-111. doi: 10.1016/j.preteyeres.2016.02.002. Epub 2016 Feb 11.
4
Unilateral Vogt-Koyanagi-Harada Disease: A Clinical Case Report.单侧Vogt-小柳-原田病：一例临床病例报告
Case Rep Ophthalmol. 2015 Oct 30;6(3):361-5. doi: 10.1159/000441616. eCollection 2015 Sep-Dec.
5
Bilateral dexamethasone intravitreal implant in a young patient with Vogt-Koyanagi-Harada disease and refractory uveitis.双侧地塞米松玻璃体内植入术用于一名患有Vogt-小柳-原田病和难治性葡萄膜炎的年轻患者。
Clin Rheumatol. 2015 Jun;34(6):1145-8. doi: 10.1007/s10067-014-2623-1. Epub 2014 Apr 25.
6
Clinical characteristics of Vogt-Koyanagi-Harada syndrome in Chinese patients.中国患者Vogt-小柳-原田综合征的临床特征
Ophthalmology. 2007 Mar;114(3):606-14. doi: 10.1016/j.ophtha.2006.07.040. Epub 2006 Nov 21.
7
Evaluation of the effect on outcomes of the route of administration of corticosteroids in acute Vogt-Koyanagi-Harada disease.评估急性Vogt-小柳-原田病中糖皮质激素给药途径对预后的影响。
Am J Ophthalmol. 2006 Jul;142(1):119-24. doi: 10.1016/j.ajo.2006.02.049.
8
Glucocorticoid use, other associated factors, and the risk of tuberculosis.糖皮质激素的使用、其他相关因素与结核病风险
Arthritis Rheum. 2006 Feb 15;55(1):19-26. doi: 10.1002/art.21705.
9
Reversion and reconversion rate of tuberculin skin reactions in correction with the use of prednisone.使用泼尼松校正时结核菌素皮肤反应的逆转和再转化率。
Dis Chest. 1960 Jul;38:51-5. doi: 10.1378/chest.38.1.51.
10
Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature.Vogt-小柳-原田病修订诊断标准：国际命名委员会报告
Am J Ophthalmol. 2001 May;131(5):647-52. doi: 10.1016/s0002-9394(01)00925-4.
Zotero 插件